NASDAQ:BILIBilibili Stock Price, Forecast & News

Bilibili's stock was trading at $25.67 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BILI stock has increased by 87.7% and is now trading at $48.18. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bilibili in the last year. There are currently 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Bilibili.

Bilibili is scheduled to release its next quarterly earnings announcement on Monday, August 24th 2020. View our earnings forecast for Bilibili.

Bilibili Inc - (NASDAQ:BILI) posted its quarterly earnings results on Monday, May, 18th. The company reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by $1.27. The business earned $327.02 million during the quarter. Bilibili had a negative net margin of 21.20% and a negative return on equity of 20.37%. View Bilibili's earnings history.

10 Wall Street analysts have issued 1-year target prices for Bilibili's stock. Their forecasts range from $17.90 to $42.00. On average, they anticipate Bilibili's stock price to reach $30.99 in the next twelve months. This suggests that the stock has a possible downside of 35.7%. View analysts' price targets for Bilibili.

News stories about BILI stock have been trending negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bilibili earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an impact on the company's share price in the next few days. View the latest news about Bilibili.

Some companies that are related to Bilibili include Workday (WDAY), Verisk Analytics (VRSK), RingCentral (RNG), PagSeguro Digital (PAGS), StoneCo (STNE), Zendesk (ZEN), Autohome (ATHM), Zynga (ZNGA), Clarivate Analytics (CCC), Pegasystems (PEGA), YY (YY), Five9 (FIVN), Proofpoint (PFPT), Globant (GLOB) and Corelogic (CLGX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bilibili investors own include Alibaba Group (BABA), IQIYI (IQ), NVIDIA (NVDA), JD.Com (JD), Baidu (BIDU), Advanced Micro Devices (AMD), Square (SQ), HUYA (HUYA), TENCENT HOLDING/ADR (TCEHY) and Baozun (BZUN).

(BILI) raised $483 million in an IPO on Wednesday, March 28th 2018. The company issued 42,000,000 shares at $10.50-$12.50 per share. Morgan Stanley, BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO.

Bilibili trades on the NASDAQ under the ticker symbol "BILI."

Bilibili's stock is owned by many different retail and institutional investors. Top institutional investors include Modus Advisors LLC (0.00%).

BILI stock was acquired by a variety of institutional investors in the last quarter, including Modus Advisors LLC.

Shares of BILI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BILI stock can currently be purchased for approximately $48.18.

Bilibili has a market capitalization of $15.71 billion and generates $973.59 million in revenue each year. The company earns $-185,150,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. Bilibili employs 4,791 workers across the globe.

The official website for Bilibili is www.bilibili.com.

Bilibili's mailing address is 17TH FLOOR BUILDING 3 GUOZHENG CENTER NO. 485 ZHENGLI ROAD YANGPU DISTRICT, SHANGHAI F4, 200433. The company can be reached via phone at 86-21-2509-9255.